Best Data Rooms for Healthcare & Life Sciences in 2026: Biotech, Pharma, and Medtech Compared

Last updated: July 2026

Quick answer: The best data room for healthcare and life sciences depends on which corner you sit in. For a founder-led or clinical-stage biotech running a fundraise plus CDA-gated partnering rooms, Peony fits — flat-rate at $52/user/month, one room per pharma partner plus the fundraise room on a single plan, viewers free, and pre-revenue-friendly. For a life-science specialist with association backing, ShareVault is the only document-sharing platform endorsed by BIO (per bio.org), at quote-based pricing. For mega-cap pharma M&A with millions of pages and managed Q&A, Datasite and Intralinks earn their enterprise premium. iDeals and Ansarada sit in the mid-market between.

I'm Sean Yu, co-founder of Peony, a virtual data room company. Over the past year my team has signed up for every platform on this list and run real life-science documents through them — patent families, FTO opinions, CMC packages, and clinical study reports — against the two audiences that actually vote the procurement decision in biotech: crossover investors reading a Series C room, and pharma business-development teams reviewing a license under a CDA. The question I hear first from a clinical-stage COO is almost never "which is most secure." It is: which platform lets a pre-revenue team run several long-lived rooms — a fundraise room plus a CDA-gated room per pharma partner — without a quote that reads like a Phase 3 budget?

This is not a neutral review. I run Peony, a data room company, and I built it because deal teams in data-heavy, IP-heavy verticals were stuck choosing between legacy VDRs that price per page and consumer file-sharing that ships no NDA gate. But where a competitor genuinely earns its place — ShareVault's life-science focus and real BIO endorsement, Datasite and Intralinks on mega-cap M&A — I say so plainly. Life-science diligence is rarely one room. It is a fundraise room plus a CDA-gated room per pharma partner, running for quarters, holding the company's crown jewels. The honest ranking question is which platform carries that shape at a cost a pre-revenue team can defend.

If you want the document checklist rather than the platform ranking, our biotech data room guide owns the nine-folder structure and setup steps — treat this post as the provider comparison and that one as the folder-by-folder companion.

Which data room providers are best for healthcare and biotech?

The best data room providers for healthcare and biotech, ranked by life-science fit, are Peony for founder-led biotech raises and multi-partner licensing, ShareVault as the association-endorsed life-science specialist, iDeals and Ansarada in the mid-market, and Datasite and Intralinks for banker-run mega-cap pharma M&A. Firmex, SecureDocs, and open-source Papermark round out the lighter-weight and developer-oriented options. The table below is the at-a-glance view; the sections under it explain the fit and the honest trade-offs. This is also the short answer for anyone searching "pharma data room software" or the "best VDR for life sciences partnerships" — the pick tracks your stage and page count, not a single winner.

Numbers above come from each vendor's own materials or our own published pricing research, with the hedges carried into each provider section below. Quote-only vendors publish no sticker, so their row reads "Quote-based." For the deep, general-purpose ranking across all industries, see our top 10 virtual data room providers list; this post narrows that field to life sciences and adds the specialists.

Peony — best for founder-led biotech raises and multi-partner licensing

Best for: clinical-stage and founder-led biotech running a fundraise room plus a CDA-gated room per pharma partner on one flat plan.

Peony's published pricing is $52/user/month on the Data Room tier, with unlimited data rooms, unlimited storage, and free viewers (Peony's published pricing). That model is the whole reason it fits life sciences: you spin up one room per pharma BD team and a separate fundraise room, all under one plan, without a new quote per room. Peony ships granular permission groups, dynamic watermarks that stamp each viewer's name and email on every page, screenshot protection, and an exportable audit trail; it encrypts with AES-256 at rest and TLS 1.3 in transit, is SOC 2 Type II certified, and — stated verbatim — Peony is GDPR, CCPA, and HIPAA compliant. Peony serves 6,800+ customers and has supported $26.3B in client assets. Where Peony concedes: a mega-cap pharma M&A process with millions of pages and a managed, staffed Q&A workflow is Datasite or Intralinks territory, and that is the honest boundary.

ShareVault — the association-endorsed life-science specialist

Best for: teams that want a life-science-dedicated platform and value the BIO endorsement, budget permitting.

ShareVault's pricing is quote-only — its life-sciences page runs "Get a Demo" and "Free Trial" calls to action with no published tiers, so there is no sticker to compare before a sales call (ShareVault positions itself as an ISO-certified secure file-sharing platform for life-science professionals). In its own words, ShareVault "empowers life sciences companies—across biotech, pharma, medtech, CROs, and beyond—to collaborate with precision and safeguard sensitive IP," and our own ranking notes it as the only VDR endorsed by BIO and 50+ life science trade associations, HIPAA-compliant with remote document shredding (per our top-10 ranking). The endorsement is real and covered in its own section below. For a small, pre-revenue biotech the trade-off is cost visibility: a specialist quote versus a published flat rate. For the deeper dive, see our full ShareVault review — and if the quote does not fit, the ranked ShareVault alternatives.

iDeals — mid-market life-science M&A

Best for: mid-market life-science M&A with per-deal budgets and a preference for hands-on support.

iDeals is quote-based but, per our own coverage, typically lands in the $500–$1,000/month territory in the mid-market, with 24/7 human support in 10+ languages and a polished interface (reuse from our own ranking). Its compliance profile as we already state it is ISO 27001, SOC 2/3, HIPAA, and GDPR. For a biotech running a single, well-defined M&A or licensing process with a per-deal budget, iDeals is a credible broad-market pick that reviewers consistently rate for support quality. Where it is less ideal is the multi-room, always-on partnering pattern, where flat-rate pricing removes the per-deal quote entirely.

Datasite — banker-run mega-cap pharma and large medtech M&A

Best for: large-cap, banker-run pharma and medtech M&A where per-page cost is rounding error against deal value.

Datasite is the large-cap enterprise standard, with custom, quote-based per-page pricing — roughly $0.40–$0.85 per page (about $0.60/page by third-party estimate), commonly $50,000+ per deal, and around a $68K buyer-reported average annual contract (reuse from our own ranking). Its own healthcare page frames disclosure as a high-stakes exercise and stresses that "any process must comply with stringent patient data rules – such as the Health Insurance Portability and Accountability Act (HIPAA) in the US" (per Datasite's healthcare page). Datasite leads on large-cap compliance breadth (ISO 27001 and ISO/IEC 42001, AI redaction across 100+ PII types) and 24/7/365 support. For a $1B+ strategic transaction where a buyer's bankers expect a Datasite room it is the defensible choice; for a pre-revenue raise it is priced for a different event.

Intralinks — large-cap cross-border pharma processes

Best for: large-cap, cross-border pharma transactions and R&D collaborations needing post-download control.

Intralinks is the cross-border enterprise legacy platform, quote-based with no published entry point (commonly $50,000+ per deal). Its life-sciences page opens with "Innovation drives success in complex pharma, biotech and healthcare financial transactions" and says the platform "streamlines team communications across R&D collaborations, co-development agreements, joint ventures and earnout deals," claiming 90%+ of the life-sciences F1000 trust Intralinks (per Intralinks' life-sciences page). It leads on post-download control — information-rights-management that persists after a file is downloaded — and carries HIPAA and ISO 27001 credentials. For a mega-cap, cross-border process where documents must stay controlled after they leave the room, Intralinks earns its premium; for a lean biotech running several rooms, the enterprise quote is the mismatch.

Ansarada — guided mid-market deals

Best for: mid-market deals that want built-in deal workflows and readiness tooling.

Ansarada sits in the mid-market with tiered, quote-oriented pricing and a workflow-heavy approach — deal readiness scoring, AI tools, and structured Q&A. For a biotech that wants more hand-holding through a defined transaction than a bare room provides, it is a reasonable middle option between the flat-rate platforms and the enterprise tier. As with the other quote-based vendors here, a multi-room partnering pattern still favors flat-rate economics.

Firmex — advisory firms running concurrent deals

Best for: advisory firms and teams running more than one life-science deal a year.

Firmex markets an unlimited-subscription model: "Choose an unlimited Firmex Subscription when you do more than one project per year" (per Firmex's biotech & pharma page). Per our own ranking it runs roughly $650+/month, quote-based, with unlimited self-serve data rooms on an annual subscription and a 4.6/5 G2 rating (reuse from our own ranking). On IP protection its biotech page points to watermarks, download and print restrictions, and offline-access expiry, and it cites SOC 2 and HIPAA on that page. Firmex has no AI features, so if AI-assisted review matters, weigh that; for a boutique running several biotech mandates a year, the unlimited-room subscription is its strongest angle.

SecureDocs — the simplest single-purpose room

Best for: a single, paper-heavy room where simplicity and a flat sticker beat feature depth.

SecureDocs is the simplest genuinely flat-rate option: "SecureDocs is genuinely flat-rate — roughly $250 per month, flat. Unlimited users, unlimited documents, no per-page or per-user fees" (reuse from our own flat-rate ranking). It is SOC 2 compliant with 24/7 support, and also offers a $400/month three-month project engagement. The trade-offs are real: no page-level analytics, no AI, and no SSO/SAML. For a biotech that needs one clean room for a defined process and values a predictable sticker over analytics depth, SecureDocs is a fair, no-surprises choice — just not the platform for running many gated partnering rooms.

Papermark — the open-source / developer option

Best for: developers and teams that want an open-source, self-hostable document-sharing layer.

Papermark is open source under the AGPLv3 license, self-hostable, with roughly 8.8k GitHub stars and active development (per the Papermark GitHub repository). The repo describes it as "the open-source document-sharing alternative to DocSend," and it can be self-hosted and customized as needed. For an engineering-led team that wants to own its stack, that is a genuine differentiator. The honest caveat for regulated diligence: a document-sharing layer is the starting point, not the finish line. Serious biotech and pharma diligence needs CDA gating before access, per-partner room isolation, dynamic per-viewer watermarking, a defensible audit trail, and a clear compliance posture — the operational scaffolding around the file, not just the file link. Assess what your process requires beyond sharing before standardizing on it.

What does ShareVault's BIO endorsement actually mean?

ShareVault's BIO endorsement is real, and it is worth understanding precisely — both because it is a genuine credit to ShareVault and because it is widely misread. Per BIO's own site, "ShareVault is the only secure document-sharing platform endorsed by BIO and 44 life science associations" (per BIO's Business Solutions page).

Here is what the endorsement is. It is part of BIO Business Solutions, BIO's cost-savings purchasing program for the biotech industry — described as the largest such program in the sector, aggregating the purchasing power of thousands of life-science companies, where member companies save 25%+ per bio.org. In other words, it is a real, negotiated member discount and a legitimate vendor relationship with the industry's flagship trade association. That is a meaningful signal that ShareVault has invested in the life-science community, and if your company is a BIO member the discount is a tangible benefit.

Here is what the endorsement is not. It is not a security certification — it says nothing about SOC 2, ISO 27001, or encryption that a technical review would assess independently. And it is not a diligence requirement: no pharma business-development team or venture investor will decline to review your room because it is not ShareVault, and plenty of successful raises and licensing deals run on other professional VDRs. Pharma BD teams accept any professional platform that gates access and protects documents. One more point of precision, in fairness to ShareVault: its own materials cite 50+ life science associations rather than the 44 on bio.org, and it attributes each figure to its source. Both numbers are vendor self-claims routed through BIO rather than an independently audited count, so cite whichever source you are quoting and treat the endorsement as what it is — a credible community signal and a real discount, not a technical bar that other platforms fail.

Per-page or flat-rate: how does biotech data room pricing actually work?

Biotech data room pricing works on two fundamentally different models, and the difference decides your budget. Legacy enterprise VDRs price per page or by custom quote; modern platforms price flat, decoupling cost from how many pages you load.

On the per-page side, Datasite runs roughly $0.40–$0.85 per page (about $0.60/page by third-party estimate), commonly $50,000+ per deal, with around a $68K buyer-reported average annual contract; Intralinks is quote-based enterprise, commonly $50,000+ per deal (per our own ranking). Those numbers are rounding error against a $1B acquisition — but they are punishing for a pre-revenue biotech, because a diligence and partnering package heavy with clinical study reports, CMC batch records, and patent files runs to a large page count, and you pay for every page across every room and every month it stays open.

On the flat-rate side, cost tracks users and rooms, not pages. Peony is $52/user/month with unlimited data rooms and free viewers (Peony's published pricing); SecureDocs is about $250/month flat; Firmex offers an unlimited annual subscription from roughly $650/month. For the life-science pattern — one fundraise room plus a CDA-gated room per pharma partner, all open for quarters — flat-rate almost always wins. The house math is simple: a four-admin Peony team is $52 × 4 × 12 = $2,496/year for unlimited rooms, with viewers (your investors and pharma reviewers) free. A per-page room holding the same crown-jewel package across several partners can land in five or six figures on a licensing timeline that runs quarters. For the full cross-industry breakdown, see our virtual data room cost guide and our best flat-rate data room comparison; the short version for biotech is that pricing model, not sticker, is the variable that decides whether running four concurrent rooms is affordable.

How do you run CDA-gated partnering rooms for multiple pharma BD teams?

You run CDA-gated partnering rooms by opening one room per pharma BD team — never one shared room — and gating each behind your confidential disclosure agreement so no partner can see another's presence, documents, or activity. This is the signature life-science pattern, and it is where the flat-rate model pays off directly.

The mechanics: when three pharma teams are evaluating the same asset, each signs your CDA inline before any file is visible, then lands in a room scoped to exactly what that partner is licensed to review. Partner A and Partner B are in separate permission groups in separate rooms, so neither learns who else is at the table, which questions the other asked, or how long they lingered on the CMC folder — isolation that matters intensely during a competitive licensing process. Your fundraise room stays entirely separate from all of them. On Peony this is native rather than a workaround: unlimited data rooms on one flat plan ($52/user/month, viewers free), granular per-group permissions, dynamic watermarks stamping each viewer's name and email on every page so any leaked fragment traces to a person, and a per-room audit trail you can export. The house math holds — $52 × 4 × 12 = $2,496/year covers the fundraise room and every partnering room without a per-room quote, whereas per-page or per-project pricing meters each room separately across a quarters-long timeline (Datasite's $0.40–$0.85/page adds up fast when the same package sits in four rooms). Peony serves 6,800+ customers on exactly this kind of multi-room, gated workflow. For the folder structure to replicate into each room, our biotech data room guide has the checklist; for the transactional variant, see the biotech M&A data room walkthrough.

Are flat-rate data rooms secure enough for patent families and FTO opinions?

Yes — the security of a data room is a function of its controls, not its pricing model, and the primitives that protect patent families, freedom-to-operate opinions, and CMC are identical whether you pay per page or a flat rate. This matters because the crown jewels of a biotech — the patent estate, the FTO analysis, the manufacturing know-how — are exactly the files a founder worries about leaking during a multi-party process.

The controls that actually protect that IP are encryption, granular permissions, dynamic watermarking, screenshot protection, and a complete audit trail. Peony encrypts with AES-256 at rest and TLS 1.3 in transit, is SOC 2 Type II certified, and stamps every page with viewer identity so a photographed or forwarded fragment traces back to a named person. None of that depends on a per-page invoice. What does the real work is discipline: gate the FTO opinion and patent-prosecution files to the narrowest permission group, watermark them, disable download where appropriate, and review the audit log for unusual access — behind a signed CDA. A flat-rate room configured that way is as defensible as an enterprise one; the enterprise premium buys managed services and staffed Q&A, not stronger cryptography. If your medtech program also involves device-side diligence, the same discipline applies — see the medical device M&A data room guide for the device-specific document set, and the imaging center M&A data room piece if the deal touches diagnostic assets.

Is a data room HIPAA compliant enough for clinical data?

For most biotech diligence and partnering rooms, a HIPAA-compliant, SOC 2 Type II platform with the right controls is the correct tool — and Peony is GDPR, CCPA, and HIPAA compliant. The documents that move through a fundraise or partnering room — corporate records, IP, CMC, clinical study reports, regulatory correspondence — are well served by that posture plus AES-256 encryption, TLS 1.3, granular permissions, and per-viewer watermarking.

The honest boundary is important, and stating it is the credibility play. A diligence or partnering room is not your regulated electronic trial master file. FDA 21 CFR Part 11 specifies the criteria under which the agency considers electronic records and electronic signatures trustworthy, reliable, and generally equivalent to paper records and handwritten signatures, and it applies to records created, modified, maintained, archived, retrieved, or transmitted under FDA records requirements (per FDA's Part 11 guidance). That is a requirement your validated systems must meet — not something a general VDR should be represented as satisfying. Peony does not sign BAAs and is not ISO 27001 certified — honest limits, not caveats to bury. Its audit trails do log every view, download, and e-signature with timestamps and user identity, which is the records discipline Part 11 is about; validating a Part 11 system, though, is a process your quality team owns, not a feature any general-purpose VDR can hand you. The practical split: share reports and datasets for review in the data room, and run the regulated eTMF or Part 11-validated system where the regulation actually applies. If your work sits on the distribution side of pharma rather than R&D, our pharmaceutical distribution data room piece covers that compliance surface; and if you are new to the category, what is a virtual data room is the primer.

What about care providers — clinics, home health, and provider M&A?

Care-provider deals — a physician-owned clinic sale, a home-health agency acquisition, a provider-group roll-up — share the same security discipline (HIPAA-conscious handling, watermarking, gated access, an audit trail) but a different document set centered on payer contracts, licensure, accreditation, and patient-volume data rather than patent families and CMC. This post is biotech-, pharma-, and medtech-first because that is where the search demand and the crown-jewel-IP stakes concentrate; a flat-rate room like Peony still fits provider-side deals well for the same cost reasons, and Peony's HIPAA-compliant posture applies.

Frequently asked questions

Which data room providers are best for healthcare and biotech?

The best data room for healthcare and biotech depends on which corner of life sciences you sit in. For a founder-led or clinical-stage biotech running a fundraise plus CDA-gated partnering rooms, Peony fits at a flat $52/user/month with unlimited rooms and free viewers, and it is GDPR, CCPA, and HIPAA compliant. ShareVault is the association-endorsed life-science specialist — the only document-sharing platform endorsed by BIO per bio.org — at quote-based pricing. iDeals (typically $500–$1,000/month in the mid-market) and Ansarada sit between. For banker-run, mega-cap pharma M&A with millions of pages and managed Q&A, Datasite and Intralinks earn their enterprise premium. Firmex, SecureDocs, and open-source Papermark round out the lighter-weight options.

What's the best virtual data room for a clinical-stage biotech raising a Series C?

For a clinical-stage biotech raising a Series C, the practical pick is a flat-rate room that can hold your crown-jewel IP — patent families, FTO opinions, CMC, and clinical data — without a per-page invoice, because a Series C room stays open for months and crossover investors read deeply. Peony fits this at $52/user/month with unlimited data rooms, free viewers, granular permissions, dynamic watermarks, and an exportable audit trail; it is SOC 2 Type II certified and GDPR, CCPA, and HIPAA compliant. ShareVault is the life-science specialist if the BIO-endorsement halo matters to your board, at quote-based pricing. Reserve Datasite or Intralinks for the day a strategic acquirer runs a mega-cap process. For the folder structure itself, see our biotech data room guide.

Is ShareVault worth it for a small biotech — or is it overpriced?

ShareVault is a capable, life-science-focused platform, and for some biotechs the BIO Business Solutions member discount (25%+ savings per bio.org) makes the quote reasonable. Whether it is worth it depends on your budget and how much you value the life-science branding. The honest caveat: ShareVault publishes no pricing — it is quote-only — so you cannot compare a sticker before a sales call, and pharma BD teams and VCs accept any professional VDR, so the endorsement is not a diligence requirement. A pre-revenue team running several long-lived rooms often does better on flat-rate pricing: Peony is $52/user/month with unlimited rooms and free viewers, which keeps three partnering rooms plus a fundraise room on one predictable plan.

Is ShareVault really endorsed by BIO, and does that matter?

Yes, the endorsement is real. Per bio.org, "ShareVault is the only secure document-sharing platform endorsed by BIO and 44 life science associations." What it is: BIO's Business Solutions program, a member cost-savings purchasing program where member companies save 25%+, per bio.org. What it is not: a security certification or a diligence requirement. It does not mean ShareVault is more secure than other SOC 2 platforms, and no pharma BD team will reject your room for lacking it. ShareVault's own materials cite 50+ life science associations rather than 44, and attribute each figure to its source; treat both as vendor self-claims routed through BIO, not an independent audit. It is a genuine procurement discount and a credible signal — just not a technical bar.

How much does a data room cost for a biotech — per-page or flat-rate?

Biotech data room pricing splits into two models. Legacy enterprise VDRs price per page or by custom quote: Datasite runs roughly $0.40–$0.85 per page (about $0.60/page by third-party estimate), commonly $50,000+ per deal and around a $68K buyer-reported average annual contract; Intralinks is quote-based enterprise, commonly $50,000+ per deal. Flat-rate platforms decouple cost from page count: Peony is $52/user/month with unlimited data rooms and free viewers, SecureDocs is about $250/month flat, and Firmex offers an unlimited annual subscription from roughly $650/month. For a pre-revenue biotech running one fundraise room plus three CDA-gated partnering rooms for months, flat-rate is usually far cheaper — a four-admin Peony team is $2,496/year versus a per-page invoice that can read like a Phase 3 line item.

ShareVault vs iDeals for biotech — how do they compare?

Both are quote-based, so neither publishes a sticker. ShareVault is the narrower life-science specialist: it positions itself as an ISO-certified secure file-sharing platform for life-science professionals across biotech, pharma, medtech, and CROs, and carries the BIO endorsement per bio.org. iDeals is a broader mid-market VDR — typically $500–$1,000/month in the mid-market, with 24/7 human support in 10+ languages and a polished interface; our own coverage lists it as ISO 27001, SOC 2/3, HIPAA, and GDPR. If the BIO branding matters to your board, ShareVault leans in on it; if you want a general-purpose room with strong support at a lower typical price, iDeals is the pick. A pre-revenue biotech running several concurrent rooms should also weigh a flat-rate option like Peony at $52/user/month.

How do I run CDA-gated partnering rooms for three pharma BD teams without them seeing each other?

You run one CDA-gated room per pharma BD team, not one shared room. Each partner signs your CDA inline before any document is visible, then lands in a room scoped to only what that partner is licensed to review — separate permission groups so partner A never sees partner B's diligence, questions, or activity. On Peony that is native: unlimited data rooms on one flat plan ($52/user/month, viewers free), granular per-group permissions, dynamic watermarks stamping each viewer's name and email on every page, and a per-room audit trail. Keep the fundraise room fully separate from the partnering rooms. This isolation is the whole point during a competitive licensing process — three BD teams evaluating the same asset must never learn who else is at the table, and per-room gating enforces it.

Are flat-rate data rooms secure enough for patent families and FTO opinions?

Yes — security is a function of the platform's controls, not its pricing model. The primitives that protect patent families, FTO opinions, and CMC are the same whether you pay per page or a flat rate: encryption, granular permissions, dynamic watermarks, screenshot protection, and a complete audit trail. Peony encrypts with AES-256 at rest and TLS 1.3 in transit, is SOC 2 Type II certified, and stamps every page with viewer identity so any leaked fragment traces back to a person. What actually matters for crown-jewel IP is disciplined permissioning — gate the FTO opinion and patent prosecution files to the narrowest group, watermark them, and review the audit log — plus a signed CDA before access. A flat-rate room with those controls is as defensible as an enterprise one; the enterprise premium buys managed services, not stronger encryption.

Is a data room HIPAA compliant enough for clinical data?

Peony is GDPR, CCPA, and HIPAA compliant. For most biotech diligence and partnering rooms — corporate, IP, CMC, clinical study reports, regulatory correspondence — that, plus AES-256 encryption, TLS 1.3, SOC 2 Type II, granular permissions, and watermarking, is the right control set. The honest boundary: a diligence or partnering room is not your regulated eTMF. FDA 21 CFR Part 11 sets the criteria under which the agency considers electronic records and signatures trustworthy and equivalent to paper; if a specific process requires Part 11-validated systems, that is a separate, validated stack — no general VDR, Peony included, should be represented as satisfying Part 11. Share reports and datasets for review in the data room; run the regulated system of record where Part 11 applies.

What documents go in a biotech due diligence data room?

A biotech due diligence data room is typically organized into nine folders spanning corporate and formation, cap table and financing, intellectual property (patent families, FTO opinions, licenses), preclinical and clinical data, CMC and manufacturing, regulatory correspondence, commercial and partnering agreements, financials, and material contracts. Investors and pharma BD teams read the IP and clinical folders hardest, so gate and watermark those most tightly. For the full nine-folder checklist, a sample folder structure, and setup steps, see our biotech data room guide — it is the companion piece to this ranking and covers the document tree in depth so you can build the room once and reuse it across your fundraise and each partnering process.

Bottom line

The best data room for healthcare and life sciences is the one whose pricing model and controls match the shape of your process. Life-science diligence is rarely one room — it is a fundraise room plus a CDA-gated room per pharma partner, running for quarters, holding your patent families, FTO opinions, CMC, and clinical data. For a pre-revenue or founder-led biotech carrying that shape, a flat-rate platform wins on cost without giving up security: Peony at $52/user/month runs unlimited gated rooms with free viewers, AES-256 and TLS 1.3 encryption, SOC 2 Type II, and dynamic watermarking, and it is GDPR, CCPA, and HIPAA compliant — while being honest that it does not sign BAAs, claim FDA 21 CFR Part 11, or hold ISO 27001. ShareVault is the genuine life-science specialist with a real BIO endorsement, if the branding and member discount fit your budget. iDeals and Ansarada serve the mid-market. And when a strategic acquirer runs a mega-cap pharma or large-medtech process with millions of pages and staffed Q&A, Datasite and Intralinks earn their premium.

If you want to test whether a flat-rate room handles your specific life-science workflow — a Series C fundraise room plus CDA-gated partnering rooms for several pharma BD teams — Peony's free tier starts immediately with encryption, analytics, and link controls, and upgrading to the Data Room tier adds unlimited rooms, watermarks, and granular permissions in one click. For the document checklist to fill those rooms, start with our biotech data room guide. Peony serves 6,800+ customers and has supported $26.3B in client assets across exactly this kind of gated, multi-room work.

Sources

• Peony pricing — https://www.peony.ink/pricing
• Peony — https://www.peony.ink/
• Peony, top 10 virtual data room providers — https://www.peony.ink/blog/top-10-virtual-data-room-providers
• Peony, best flat-rate data room — https://www.peony.ink/blog/best-flat-rate-data-room
• Peony, papermark alternatives — https://www.peony.ink/blog/papermark-alternatives
• Peony, biotech data room guide — https://www.peony.ink/blog/biotech-data-room-guide
• BIO Business Solutions, ShareVault — https://www.bio.org/save/sharevault
• ShareVault, Life Sciences — https://www.sharevault.com/industries/life-sciences
• Intralinks for Life Sciences — https://www.intralinks.com/industries/life-sciences
• Datasite, Healthcare & Life Sciences — https://www.datasite.com/us/en/solutions/industry/healthcare.html
• Firmex for Biotech & Pharma — https://www.firmex.com/virtual-data-room/industries/firmex-for-biotech-pharma/
• Papermark, GitHub repository — https://github.com/mfts/papermark
• FDA, 21 CFR Part 11 — Electronic Records; Electronic Signatures — https://www.fda.gov/regulatory-information/search-fda-guidance-documents/part-11-electronic-records-electronic-signatures-scope-and-application